Vertex to Announce Third-Quarter 2019 Financial Results on October 30
October 21 2019 - 4:07PM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report
its third quarter 2019 financial results on Wednesday, October 30,
2019 after the financial markets close. The company will host a
conference call and webcast at 5:00 p.m. ET. To access the call,
please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001
(International).
The conference call will be webcast live and a link to the
webcast can be accessed through Vertex's website at www.vrtx.com in
the "Investors" section. To ensure a timely connection, it is
recommended that participants register at least 15 minutes prior to
the scheduled webcast. An archived webcast will be available on the
company's website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious diseases. The company has three approved medicines
that treat the underlying cause of cystic fibrosis (CF) — a rare,
life-threatening genetic disease — and has several ongoing clinical
and research programs in CF. Beyond CF, Vertex has a robust
pipeline of investigational medicines in other serious diseases
where it has deep insight into causal human biology, such as sickle
cell disease, beta thalassemia, pain, alpha-1 antitrypsin
deficiency, Duchenne muscular dystrophy and APOL1-mediated kidney
diseases.
Founded in 1989 in Cambridge, Mass., Vertex's global
headquarters is now located in Boston's Innovation District and its
international headquarters is in London, UK. Additionally, the
company has research and development sites and commercial offices
in North America, Europe, Australia and Latin America. Vertex is
consistently recognized as one of the industry's top places to
work, including nine consecutive years on Science magazine's Top
Employers list and top five on the 2019 Best Employers for
Diversity list by Forbes. For company updates and to learn more
about Vertex's history of innovation, visit www.vrtx.com or follow
us on Facebook, Twitter, LinkedIn, YouTube and Instagram.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191021005799/en/
Vertex Investor Contacts: Michael Partridge, 617-341-6108
Zach Barber, 617-341-6470 Leah Gibson, 617-961-1507
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024